Currently, five anti-TNF therapeutics and additional biosimilars thereof are approved and successfully used to treat autoimmune diseases, including rheumatoid arthritis (RA), juvenile RA, inflammatory bowel disease, psoriasis, and ankylosing spondylitis (4). The gene discussed is TNF; the disease is autoimmune disease.